Carbonylation Modification Regulates Na/K-ATPase Signaling and Salt Sensitivity: A Review and a Hypothesis

Frontiers in Physiology

Volumn 7, Issue , 2016, Pages

  Shah, Preeya T ^a   Martin, Rebecca ^a   Yan, Yanling ^a   Shapiro, Joseph I ^a   Liu, Jiang ^a  

^a MARSHALL UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Na K ATPase; protein carbonylation; ROS; signaling

Indexed keywords

EID: 85015811994     PISSN: None     EISSN: 1664042X     Source Type: Journal    
DOI: 10.3389/fphys.2016.00256     Document Type: Review

References (134)

1. Anderson D. E. Fedorova O. V. Morrell C. H. Longo D. L. Kashkin V. A. Metzler J. D. et al. (2008). Endogenous sodium pump inhibitors and age-associated increases in salt sensitivity of blood pressure in normotensives. Am. J. Physiol. Regul. Integr. Comp. Physiol. 294, R1248–R1254. 10.1152/ajpregu.00782.200718287222
2. Aperia A. (2007). New roles for an old enzyme: Na,K-ATPase emerges as an interesting drug target. J. Intern. Med. 261, 44–52. 10.1111/j.1365-2796.2006.01745.x17222167
3. Bagrov A. Y. Shapiro J. I. (2008). Endogenous digitalis: pathophysiologic roles and therapeutic applications. Nat. Clin. Pract. Nephrol. 4, 378–392. 10.1038/ncpneph084818542120
4. Bagrov A. Y. Shapiro J. I. Fedorova O. V. (2009). Endogenous cardiotonic steroids: physiology, pharmacology, and novel therapeutic targets. Pharmacol. Rev. 61, 9–38. 10.1124/pr.108.00071119325075
5. Banday A. A. Lokhandwala M. F. (2011). Angiotensin II-mediated biphasic regulation of proximal tubular Na+/H+ exchanger 3 is impaired during oxidative stress. Am. J. Physiol. Renal Physiol. 301, F364–F370. 10.1152/ajprenal.00121.201121593187
6. Barwe S. P. Anilkumar G. Moon S. Y. Zheng Y. Whitelegge J. P. Rajasekaran S. A. et al. (2005). Novel role for Na,K-ATPase in phosphatidylinositol 3-kinase signaling and suppression of cell motility. Mol. Biol. Cell 16, 1082–1094. 10.1091/mbc.e04-05-042715616195
7. Beggah A. T. Geering K. (1997). Alpha and beta subunits of Na,K-ATPase interact with BiP and calnexin. Ann. N.Y. Acad. Sci. 834, 537–539. 10.1111/j.1749-6632.1997.tb52311.x9405855
8. Bertorello A. M. Sznajder J. I. (2005). The dopamine paradox in lung and kidney epithelia: sharing the same target but operating different signaling networks. Am. J. Respir. Cell Mol. Biol. 33, 432–437. 10.1165/rcmb.2005-0297tr16234332
9. Bibert S. Liu C. C. Figtree G. A. Garcia A. Hamilton E. J. Marassi F. M. et al. (2011). FXYD proteins reverse inhibition of the Na+-K+ pump mediated by glutathionylation of its β1 subunit. J. Biol. Chem. 286, 18562–18572. 10.1074/jbc.M110.18410121454534
10. Blanco G. Mercer R. W. (1998). Isozymes of the Na-K-ATPase: heterogeneity in structure, diversity in function. Am. J. Physiol. 275, F633–F650. 9815123
11. Blaustein M. P. (1977). Sodium ions, calcium ions, blood pressure regulation, and hypertension: a reassessment and a hypothesis. Am. J. Physiol. Cell Physiol. 232, C165–C173. 324293
12. Blaustein M. P. Zhang J. Chen L. Song H. Raina H. Kinsey S. P. et al. (2009). The pump, the exchanger, and endogenous ouabain: signaling mechanisms that link salt retention to hypertension. Hypertension 53, 291–298. 10.1161/HYPERTENSIONAHA.108.11997419104005
13. Bogdanova I. P. A. Boldyrev A. Gassmann M. (2006). Oxygen- and redox-induced regulation of the Na/K ATPase. Curr. Enzym. Inhib. 2, 37–59. 10.2174/157340806775473490
14. Buckalew V. M. (2005). Endogenous digitalis-like factors. An historical overview. Front. Biosci. 10, 2325–2334. 10.2741/170115970498
15. Cai H. Wu L. Qu W. Malhotra D. Xie Z. Shapiro J. I. et al. (2008). Regulation of apical NHE3 trafficking by ouabain-induced activation of the basolateral Na+-K+-ATPase receptor complex. Am. J. Physiol. Cell Physiol. 294, C555–C563. 10.1152/ajpcell.00475.200718077602
16. Calhoun D. A. Jones D. Textor S. Goff D. C. Murphy T. P. Toto R. D. et al. (2008). Resistant hypertension: diagnosis, evaluation, and treatment: a scientific statement from the american heart association professional education committee of the council for high blood pressure research. Hypertension 51, 1403–1419. 10.1161/HYPERTENSIONAHA.108.18914118391085
17. Crajoinas R. O. Lessa L. M. Carraro-Lacroix L. R. Davel A. P. Pacheco B. P. Rossoni L. V. et al. (2010). Posttranslational mechanisms associated with reduced NHE3 activity in adult vs. young prehypertensive SHR. Am. J. Physiol. Renal Physiol. 299, F872–F881. 10.1152/ajprenal.00654.200920630932
18. Dahl L. K. Heine M. Tassinari L. (1962). Role of genetic factors in susceptibility to experimental hypertension due to chronic excess salt ingestion. Nature 194, 480–482. 10.1038/194480b013883090
19. Dahl L. K. Heine M. Thompson K. (1974). Genetic influence of the kidneys on blood pressure. Evidence from chronic renal homografts in rats with opposite predispositions to hypertension. Circ. Res. 40, 94–101. 10.1161/01.RES.40.4.944588315
20. Dalle-Donne I. Aldini G. Carini M. Colombo R. Rossi R. Milzani A. (2006b). Protein carbonylation, cellular dysfunction, and disease progression. J. Cell. Mol. Med. 10, 389–406. 10.1111/j.1582-4934.2006.tb00407.x16796807
21. Dalle-Donne I. Giustarini D. Colombo R. Rossi R. Milzani A. (2003). Protein carbonylation in human diseases. Trends Mol. Med. 9, 169–176. 10.1016/S1471-4914(03)00031-512727143
22. Dalle-Donne I. Rossi R. Colombo R. Giustarini D. Milzani A. (2006a). Biomarkers of oxidative damage in human disease. Clin. Chem. 52, 601–623. 10.1373/clinchem.2005.06140816484333
23. de Wardener H. E. Clarkson E. M. (1985). Concept of natriuretic hormone. Physiol. Rev. 65, 658–759. 2989958
24. Dobrota D. Matejovicova M. Kurella E. G. Boldyrev A. A. (1999). Na/K-ATPase under oxidative stress: molecular mechanisms of injury. Cell. Mol. Neurobiol. 19, 141–149. 10.1023/A:100690992728710079973
25. Dostanic-Larson I. Van Huysse J. W. Lorenz J. N. Lingrel J. B. (2005). The highly conserved cardiac glycoside binding site of Na,K-ATPase plays a role in blood pressure regulation. Proc. Natl. Acad. Sci. U.S.A. 102, 15845–15850. 10.1073/pnas.050735810216243970
26. Ellis D. Z. Rabe J. Sweadner K. J. (2003). Global loss of Na,K-ATPase and its nitric oxide-mediated regulation in a transgenic mouse model of amyotrophic lateral sclerosis. J. Neurosci. 23, 43–51. 12514200
27. Elkareh J. Kennedy D. J. Yashaswi B. Vetteth S. Shidyak A. Kim E. G. et al. (2007). Marinobufagenin stimulates fibroblast collagen production and causes fibrosis in experimental uremic cardiomyopathy. Hypertension 49, 215–224. 10.1161/01.HYP.0000252409.36927.0517145984
28. Fedorova O. V. Agalakova N. I. Talan M. I. Lakatta E. G. Bagrov A. Y. (2005). Brain ouabain stimulates peripheral marinobufagenin via angiotensin II signalling in NaCl-loaded Dahl-S rats. J. Hypertens. 23, 1515–1523. 10.1097/01.hjh.0000174969.79836.8b16003178
29. Fedorova O. V. Kolodkin N. I. Agalakova N. I. Lakatta E. G. Bagrov A. Y. (2001). Marinobufagenin, an endogenous alpha-1 sodium pump ligand, in hypertensive Dahl salt-sensitive rats. Hypertension 37, 462–466. 10.1161/01.HYP.37.2.46211230319
30. Fedorova O. V. Lakatta E. G. Bagrov A. Y. (2000). Endogenous Na,K pump ligands are differentially regulated during acute NaCl loading of Dahl Rats. Circulation 102, 3009–3014. 10.1161/01.cir.102.24.300911113054
31. Fedorova O. V. Shapiro J. I. Bagrov A. Y. (2010). Endogenous cardiotonic steroids and salt-sensitive hypertension. Biochim. Biophys. Acta 1802, 1230–1236. 10.1016/j.bbadis.2010.03.01120347967
32. Fedorova O. V. Talan M. I. Agalakova N. I. Lakatta E. G. Bagrov A. Y. (2002). Endogenous ligand of alpha(1) sodium pump, marinobufagenin, is a novel mediator of sodium chloride–dependent hypertension. Circulation 105, 1122–1127. 10.1161/hc0902.10471011877366
33. Ferrandi M. Molinari I. Barassi P. Minotti E. Bianchi G. Ferrari P. (2004). Organ hypertrophic signaling within caveolae membrane subdomains triggered by ouabain and antagonized by PST 2238. J. Biol. Chem. 279, 33306–33314. 10.1074/jbc.m40218720015161929
34. Feschenko M. S. Wetzel R. K. Sweadner K. J. (1997). Phosphorylation of Na,K-ATPase by protein kinases. Sites, susceptibility, and consequences. Ann. N.Y. Acad. Sci. 834, 479–488. 10.1111/j.1749-6632.1997.tb52306.x9405850
35. Figtree G. A. Keyvan Karimi G. Liu C. C. Rasmussen H. H. (2012). Oxidative regulation of the Na(+)-K(+) pump in the cardiovascular system. Free Radic. Biol. Med. 53, 2263–2268. 10.1016/j.freeradbiomed.2012.10.53923085513
36. Figtree G. A. Liu C. C. Bibert S. Hamilton E. J. Garcia A. White C. N. et al. (2009). Reversible oxidative modification: a key mechanism of Na+-K+ pump regulation. Circ. Res. 105, 185–193. 10.1161/CIRCRESAHA.109.19954719542013
37. Fisher K. A. Lee S. H. Walker J. Dileto-Fang C. Ginsberg L. Stapleton S. R. (2001). Regulation of proximal tubule sodium/hydrogen antiporter with chronic volume contraction. Am. J. Physiol. Renal Physiol. 280, F922–F926. 11292636
38. Foulkes R. Ferrario R. G. Salvati P. Bianchi G. (1992). Differences in ouabain-induced natriuresis between isolated kidneys of Milan hypertensive and normotensive rats. Clin. Sci. 82, 185–190. 10.1042/cs08201851311656
39. Garvin J. L. Ortiz P. A. (2003). The role of reactive oxygen species in the regulation of tubular function. Acta Physiol. Scand. 179, 225–232. 10.1046/j.0001-6772.2003.01203.x14616238
40. Go Y. M. Jones D. P. (2013). The redox proteome. J. Biol. Chem. 288, 26512–26520. 10.1074/jbc.r113.46413123861437
41. Guyton A. C. (1991). Blood pressure control–special role of the kidneys and body fluids. Science 252, 1813–1816. 10.1126/science.20631932063193
42. Haddy F. J. Pamnani M. B. (1998). Role of ouabain-like factors and Na-K-ATPase inhibitors in hypertension–some old and recent findings. Clin. Exp. Hypertens. 20, 499–508. 10.3109/106419698090532289682906
43. Haddy F. J. Pamnani M. B. Clough D. L. (1979). Humoral factors and the sodium-potassium pump in volume expanded hypertension. Life Sci. 24, 2105–2117. 10.1016/0024-3205(79)90108-5384124
44. Hamlyn J. M. Blaustein M. P. Bova S. DuCharme D. W. Harris D. W. Mandel F. et al. (1991). Identification and characterization of a ouabain-like compound from human plasma. Proc. Natl. Acad. Sci. U.S.A. 88, 6259–6263. 10.1073/pnas.88.14.62591648735
45. Han H. J. Lee Y. J. Park S. H. Lee J. H. Taub M. (2005). High glucose-induced oxidative stress inhibits Na+/glucose cotransporter activity in renal proximal tubule cells. Am. J. Physiol. Renal Physiol. 288, F988–F996. 10.1152/ajprenal.00327.200415598843
46. Han W. Li H. V. Villar A. M. Pascua A. M. Dajani M. I. Wang X. et al. (2008). Lipid rafts keep NADPH oxidase in the inactive state in human renal proximal tubule cells. Hypertension 51, 481–487. 10.1161/HYPERTENSIONAHA.107.10327518195159
47. He F. J. MacGregor G. A. (2004). Effect of longer-term modest salt reduction on blood pressure. Cochrane Database Syst. Rev. 3:CD004937. 10.1002/14651858.CD00493724192084
48. Huang H. Y. Caballero B. Chang S. Alberg A. J. Semba R. D. Schneyer C. R. et al. (2006). The efficacy and safety of multivitamin and mineral supplement use to prevent cancer and chronic disease in adults: a systematic review for a national institutes of health state-of-the-science conference. Ann. Intern. Med. 145, 372–385. 10.7326/0003-4819-145-5-200609050-0013516880453
49. Huang W. H. Wang Y. Askari A. (1992). (Na+ + K+)-ATPase: inactivation and degradation induced by oxygen radicals. Int. J. Biochem. 24, 621–626. 10.1016/0020-711X(92)90337-Z1325381
50. Joe G. M. B. (2006). Genetic Analysis of Inherited Hypertension in the Rat. Amsterdam: Elsevier Science.
51. Johns E. J. O'shaughnessy B. O'Neill S. Lane B. Healy V. (2010). Impact of elevated dietary sodium intake on NAD(P)H oxidase and SOD in the cortex and medulla of the rat kidney. Am. J. Physiol. Regul. Integr. Comp. Physiol. 299, R234–R240. 10.1152/ajpregu.00541.200920427726
52. Jordan C. Püschel B. Koob R. Drenckhahn D. (1995). Identification of a binding motif for ankyrin on the alpha-subunit of Na+,K(+)-ATPase. J. Biol. Chem. 270, 29971–29975. 10.1074/jbc.270.50.299718530398
53. Kaplan J. H. (2002). Biochemistry of Na,K-ATPase. Annu. Rev. Biochem. 71, 511–535. 10.1146/annurev.biochem.71.102201.14121812045105
54. Kaplan J. H. (2005). A moving new role for the sodium pump in epithelial cells and carcinomas. Sci. STKE 2005:pe31. 10.1126/stke.2892005pe3115972700
55. Kaunitz J. D. (2006). Membrane transport proteins: not just for transport anymore. Am. J. Physiol. Renal Physiol. 290, F995–F996. 10.1152/ajprenal.00515.200516601299
56. Kennedy D. J. Vetteth S. Periyasamy S. M. Kanj M. Fedorova L. Khouri S. et al. (2006a). Central role for the cardiotonic steroid marinobufagenin in the pathogenesis of experimental uremic cardiomyopathy. Hypertension 47, 488–495. 10.1161/01.HYP.0000202594.82271.9216446397
57. Kennedy D. J. Vetteth S. Xie M. Periyasamy S. M. Xie Z. Han C. et al. (2006b). Ouabain decreases sarco(endo)plasmic reticulum calcium ATPase activity in rat hearts by a process involving protein oxidation. Am. J. Physiol. Heart Circ. Physiol. 291, H3003–H3011. 10.1152/ajpheart.00603.200616861692
58. Kim M. S. Akera T. (1987). O2 free radicals: cause of ischemia-reperfusion injury to cardiac Na+-K+-ATPase. Am. J. Physiol. Heart Circ. Physiol. 252, H252–H257. 3028176
59. Kitiyakara C. Chabrashvili T. Chen Y. Blau J. Karber A. Aslam S. et al. (2003). Salt intake, oxidative stress, and renal expression of NADPH oxidase and superoxide dismutase. J. Am. Soc. Nephrol. 14, 2775–2782. 10.1097/01.asn.0000092145.90389.6514569087
60. Laredo J. Shah J. R. Lu Z. R. Hamilton B. P. Hamlyn J. M. (1997). Angiotensin II stimulates secretion of endogenous ouabain from bovine adrenocortical cells via angiotensin type 2 receptors. Hypertension 29, 401–407. 10.1161/01.HYP.29.1.4019039134
61. Lee K. Jung J. Kim M. Guidotti G. (2001). Interaction of the alpha subunit of Na,K-ATPase with cofilin. Biochem. J. 353, 377–385. 10.1042/bj353037711139403
62. Liu C. C. Garcia A. Mahmmoud Y. A. Hamilton E. J. Galougahi K. K. N. Fry G. A. et al. (2012). Susceptibility of β1 Na+-K+ pump subunit to glutathionylation and oxidative inhibition depends on conformational state of pump. J. Biol. Chem. 287, 12353–12364. 10.1074/jbc.M112.34089322354969
63. Liu J. Kesiry R. Periyasamy S. M. Malhotra D. Xie Z. Shapiro J. I. (2004). Ouabain induces endocytosis of plasmalemmal Na/K-ATPase in LLC-PK1 cells by a clathrin-dependent mechanism. Kidney Int. 66, 227–241. 10.1111/j.1523-1755.2004.00723.x15200429
64. Liu J. Liang M. Liu L. Malhotra D. Xie Z. Shapiro J. I. (2005). Ouabain-induced endocytosis of the plasmalemmal Na/K-ATPase in LLC-PK1 cells requires caveolin-1. Kidney Int. 67, 1844–1854. 10.1111/j.1523-1755.2005.00283.x15840032
65. Liu J. Periyasamy S. M. Gunning W. Fedorova O. V. Bagrov A. Y. Malhotra D. et al. (2002). Effects of cardiac glycosides on sodium pump expression and function in LLC-PK1 and MDCK cells. Kidney Int. 62, 2118–2125. 10.1046/j.1523-1755.2002.00672.x12427136
66. Liu J. Shapiro J. I. (2007). Regulation of sodium pump endocytosis by cardiotonic steroids: Molecular mechanisms and physiological implications. Pathophysiology 14, 171–181. 10.1016/j.pathophys.2007.09.00817961998
67. Liu J. Tian J. Haas M. Shapiro J. I. Askari A. Xie Z. (2000). Ouabain interaction with cardiac Na+/K+-ATPase initiates signal cascades independent of changes in intracellular Na+ and Ca2+ concentrations. J. Biol. Chem. 275, 27838–27844. 10.1074/jbc.M00295020010874029
68. Liu J. Xie Z. J. (2010). The sodium pump and cardiotonic steroids-induced signal transduction protein kinases and calcium-signaling microdomain in regulation of transporter trafficking. Biochim. Biophys. Acta 1802, 1237–1245. 10.1016/j.bbadis.2010.01.01320144708
69. Liu J. Yan Y. Liu L. Xie Z. Malhotra D. Joe B. et al. (2011). Impairment of Na/K-ATPase signaling in renal proximal tubule contributes to Dahl salt-sensitive hypertension. J. Biol. Chem. 286, 22806–22813. 10.1074/jbc.m111.24624921555512
70. Li Z. Xie Z. (2009). The Na/K-ATPase/Src complex and cardiotonic steroid-activated protein kinase cascades. Pflugers Arch. 457, 635–644. 10.1007/s00424-008-0470-018283487
71. Liu L. Li J. Liu J. Yuan Z. Pierre S. V. Qu W. et al. (2006). Involvement of Na+/K+-ATPase in hydrogen peroxide-induced hypertrophy in cardiac myocytes. Free Radic. Biol. Med. 41, 1548–1556. 10.1016/j.freeradbiomed.2006.08.01817045923
72. Loreaux E. L. Kaul B. Lorenz J. N. Lingrel J. B. (2008). Ouabain-sensitive alpha1 Na,K-ATPase enhances natriuretic response to saline load. J. Am. Soc. Nephrol. 19, 1947–1954. 10.1681/ASN.200802017418667729
73. Manunta P. Hamilton B. P. Hamlyn J. M. (2006). Salt intake and depletion increase circulating levels of endogenous ouabain in normal men. Am. J. Physiol. Regul. Integr. Comp. Physiol. 290, R553–R559. 10.1152/ajpregu.00648.200516467503
74. McDonough A. A. (2010). Mechanisms of proximal tubule sodium transport regulation that link extracellular fluid volume and blood pressure. Am. J. Physiol. Regul. Integr. Comp. Physiol. 298, R851–R861. 10.1152/ajpregu.00002.201020106993
75. Meneton P. Jeunemaitre X. de Wardener H. E. MacGregor G. A. (2005). Links between dietary salt intake, renal salt handling, blood pressure, and cardiovascular diseases. Physiol. Rev. 85, 679–715. 10.1152/physrev.00056.200315788708
76. Meng S. Roberts L. J. Cason G. W. Curry T. S. Manning R. D. (2002). Superoxide dismutase and oxidative stress in Dahl salt-sensitive and -resistant rats. Am. J. Physiol. Regul. Integr. Comp. Physiol. 283, R732–R738. 10.1152/ajpregu.00346.200112185008
77. Mense M. Stark G. Apell H. J. (1997). Effects of free radicals on partial reactions of the Na,K-ATPase. J. Membr. Biol. 156, 63–71. 10.1007/s0023299001889070465
78. Moe O. W. Tejedor A. Levi M. Seldin D. W. Preisig P. A. Alpern R. J. (1991). Dietary NaCl modulates Na(+)-H+ antiporter activity in renal cortical apical membrane vesicles. Am. J. Physiol. Renal Physiol. 260, F130–F137. 1847012
79. Mokry M. Cuppen E. (2008). The Atp1a1 gene from inbred Dahl salt sensitive rats does not contain the A1079T missense transversion. Hypertension 51, 922–927. 10.1161/HYPERTENSIONAHA.107.10841518285611
80. Munzel T. Gori T. Bruno R. M. Taddei S. (2010). Is oxidative stress a therapeutic target in cardiovascular disease? Eur. Heart J. 31, 2741–2748. 10.1093/eurheartj/ehq39620974801
81. Nesher M. Dvela M. Igbokwe V. U. Rosen H. Lichtstein D. (2009). Physiological roles of endogenous ouabain in normal rats. Am. J. Physiol. Heart Circ. Physiol. 297, H2026–H2034. 10.1152/ajpheart.00734.200919837951
82. Nishi A. Bertorello A. M. Aperia A. (1993). Renal Na+,K(+)-ATPase in Dahl salt-sensitive rats: K+ dependence, effect of cell environment and protein kinases. Acta Physiol. Scand. 149, 377–384. 10.1111/j.1748-1716.1993.tb09633.x8310842
83. Nyström T. (2005). Role of oxidative carbonylation in protein quality control and senescence. EMBO J. 24, 1311–1317. 10.1038/sj.emboj.760059915775985
84. Oweis S. Wu L. Kiela P. R. Zhao H. Malhotra D. Ghishan F. K. et al. (2006). Cardiac glycoside downregulates NHE3 activity and expression in LLC-PK1 cells. Am. J. Physiol. Renal Physiol. 290, F997–F1008. 10.1152/ajprenal.00322.200516352745
85. Panico C. Luo Z. Damiano S. Artigiano F. Gill P. Welch W. J. (2009). Renal proximal tubular reabsorption is reduced in adult spontaneously hypertensive rats: roles of superoxide and Na+/H+ exchanger 3. Hypertension 54, 1291–1297. 10.1161/hypertensionaha.109.13478319805644
86. Periyasamy S. M. Liu J. Tanta F. Kabak B. Wakefield B. Malhotra D. et al. (2005). Salt loading induces redistribution of the plasmalemmal Na/K-ATPase in proximal tubule cells. Kidney Int. 67, 1868–1877. 10.1111/j.1523-1755.2005.00285.x15840034
87. Petrushanko I. Bogdanov N. Bulygina E. Grenacher B. Leinsoo T. Boldyrev A. et al. (2006). Na-K-ATPase in rat cerebellar granule cells is redox sensitive. Am. J. Physiol. Regul. Integr. Comp. Physiol. 290, R916–R925. 10.1152/ajpregu.00038.200516293684
88. Petrushanko I. Y. Yakushev S. Mitkevich V. A. Kamanina Y. V. Ziganshin R. H. Meng X. et al. (2012). S-glutathionylation of the Na,K-ATPase catalytic alpha subunit is a determinant of the enzyme redox sensitivity. J. Biol. Chem. 287, 32195–32205. 10.1074/jbc.M112.39109422798075
89. Rapp J. P. (1982). Dahl salt-susceptible and salt-resistant rats. A review. Hypertension 4, 753–763. 10.1161/01.hyp.4.6.7536754600
90. Rapp J. P. Dene H. (1985). Development and characteristics of inbred strains of Dahl salt-sensitive and salt-resistant rats. Hypertension 7, 340–349. 3997219
91. Reifenberger M. S. Arnett K. L. Gatto C. Milanick M. A. (2008). The reactive nitrogen species peroxynitrite is a potent inhibitor of renal Na-K-ATPase activity. Am. J. Physiol. Renal Physiol. 295, F1191–F1198. 10.1152/ajprenal.90296.200818701626
92. Sanchez G. Nguyen A. N. Timmerberg B. Tash J. S. Blanco G. (2006). The Na,K-ATPase alpha4 isoform from humans has distinct enzymatic properties and is important for sperm motility. Mol. Hum. Reprod. 12, 565–576. 10.1093/molehr/gal06216861705
93. Schoner W. Scheiner-Bobis G. (2007). Endogenous and exogenous cardiac glycosides: their roles in hypertension, salt metabolism, and cell growth. Am. J. Physiol. Cell Physiol. 293, C509–C536. 10.1152/ajpcell.00098.200717494630
94. Schoner W. Scheiner-Bobis G. (2008). Role of endogenous cardiotonic steroids in sodium homeostasis. Nephrol. Dial. Transpl. 23, 2723–2729. 10.1093/ndt/gfn32518556748
95. Schreck C. O'Connor P. M. (2011). NAD(P)H oxidase and renal epithelial ion transport. Am. J. Physiol. Regul. Integr. Comp. Physiol. 300, R1023–R1029. 10.1152/ajpregu.00618.201021270341
96. Seshiah P. N. Weber D. S. Rocic P. Valppu L. Taniyama Y. Griendling K. K. (2002). Angiotensin II stimulation of NAD(P)H oxidase activity. Circ. Res. 91, 406–413. 10.1161/01.RES.0000033523.08033.1612215489
97. Silva E. Soares-da-Silva P. (2007). Reactive oxygen species and the regulation of renal Na+-K+-ATPase in opossum kidney cells. Am. J. Physiol. Regul. Integr. Comp. Physiol. 293, R1764–R1770. 10.1152/ajpregu.00425.200717670864
98. Soares-da-Silva E. S. A. P. (2012). Renal redox balance and Na+,K+-ATPase regulation: role in physiology and pathophysiology, in Oxidative Stress-Molecular Mechanisms and Biological Effects, ed Lushchak D. V. (Rijeka: InTech), 157–172.
99. Song H. Lee M. Y. Kinsey S. P. Weber D. J. Blaustein M. P. (2006). An N-terminal sequence targets and tethers Na+ pump alpha2 subunits to specialized plasma membrane microdomains. J. Biol. Chem. 281, 12929–12940. 10.1074/jbc.M50745020016524882
100. Stadtman E. R. Berlett B. S. (1991). Fenton chemistry. Amino acid oxidation. J. Biol. Chem. 266, 17201–17211. 1894614
101. Stadtman E. R. Levine R. L. (2000). Protein oxidation. Ann. N.Y. Acad. Sci. 899, 191–208. 10.1111/j.1749-6632.2000.tb06187.x10863540
102. Summa V. Camargo S. M. Bauch C. Zecevic M. Verrey F. (2004). Isoform specificity of human Na(+), K(+)-ATPase localization and aldosterone regulation in mouse kidney cells. J. Physiol. 555, 355–364. 10.1113/jphysiol.2003.05427014694143
103. Sweadner K. J. (1989). Isozymes of the Na+/K+-ATPase. Biochim. Biophys. Acta 988, 185–220. 10.1016/0304-4157(89)90019-12541792
104. Taylor N. E. Glocka P. Liang M. Cowley A. W. (2006). NADPH oxidase in the renal medulla causes oxidative stress and contributes to salt-sensitive hypertension in Dahl S Rats. Hypertension 47, 692–698. 10.1161/01.HYP.0000203161.02046.8d16505210
105. Thevenod F. Friedmann J. M. (1999). Cadmium-mediated oxidative stress in kidney proximal tubule cells induces degradation of Na+/K(+)-ATPase through proteasomal and endo-/lysosomal proteolytic pathways. FASEB J. 13, 1751–1761. 10506578
106. Tian J. Cai T. Yuan Z. Wang H. Liu L. Haas M. et al. (2006). Binding of Src to Na+/K+-ATPase forms a functional signaling complex. Mol. Biol. Cell 17, 317–326. 10.1091/mbc.E05-08-073516267270
107. Tian J. Liu J. Garlid K. D. Shapiro J. I. Xie Z. (2003). Involvement of mitogen-activated protein kinases and reactive oxygen species in the inotropic action of ouabain on cardiac myocytes. A potential role for mitochondrial K(ATP) channels. Mol. Cell. Biochem. 242, 181–187. 10.1023/A:102111450156112619881
108. Touyz R. M. (2004). Reactive oxygen species, vascular oxidative stress, and redox signaling in hypertension: what is the clinical significance? Hypertension 44, 248–252. 10.1161/01.HYP.0000138070.47616.9d15262903
109. Touyz R. M. (2006). Lipid rafts take center stage in endothelial cell redox signaling by death receptors. Hypertension 47, 16–18. 10.1161/01.hyp.0000196730.13216.f316344370
110. Vaziri N. D. Rodriguez-Iturbe B. (2006). Mechanisms of disease: oxidative stress and inflammation in the pathogenesis of hypertension. Nat. Clin. Pract. Nephrol. 2, 582–593. 10.1038/ncpneph028317003837
111. Wang X. Armando I. Upadhyay K. Pascua A. Jose P. A. (2009). The regulation of proximal tubular salt transport in hypertension: an update. Curr. Opin. Nephrol. Hypertens. 18, 412–420. 10.1097/mnh.0b013e32832f577519654544
112. Wang Y. Ye Q. Liu C. Xie J. X. Yan Y. Lai F. et al. (2014). Involvement of Na/K-ATPase in hydrogen peroxide-induced activation of the Src/ERK pathway in LLC-PK1 cells. Free Radic. Biol. Med. 71, 415–426. 10.1016/j.freeradbiomed.2014.03.03624703895
113. Welch W. J. (2006). Intrarenal oxygen and hypertension. Clin. Exp. Pharmacol. Physiol. 33, 1002–1005. 10.1111/j.1440-1681.2006.04478.x17002680
114. White C. N. Figtree G. A. Liu C. C. Garcia A. Hamilton E. J. Chia K. K. et al. (2009). Angiotensin II inhibits the Na+-K+ pump via PKC-dependent activation of NADPH oxidase. Am. J. Physiol. Cell Physiol. 296, C693–C700. 10.1152/ajpcell.00648.200819193863
115. Wilcox C. S. (2005). Oxidative stress and nitric oxide deficiency in the kidney: a critical link to hypertension? Am. J. Physiol. Regul. Integr. Comp. Physiol. 289, R913–R935. 10.1152/ajpregu.00250.200516183628
116. Wong C. M. Bansal G. Marcocci L. Suzuki Y. J (2012). Proposed role of primary protein carbonylation in cell signaling. Redox Rep. 17, 90–94. 10.1179/1351000212Y.000000000722564352
117. Wong C. M. Cheema A. K. Zhang L. Suzuki Y. J. (2008). Protein carbonylation as a novel mechanism in redox signaling. Circ. Res. 102, 310–318. 10.1161/circresaha.107.15981418079412
118. Wong C. M. Marcocci L. Das D. Wang X. Luo H. Zungu-Edmondson M. et al. (2013). Mechanism of protein decarbonylation. Free Radic. Biol. Med. 65, 1126–1133. 10.1016/j.freeradbiomed.2013.09.00524044890
119. Wong C. M. Marcocci L. Liu L. Suzuki Y. J. (2010). Cell signaling by protein carbonylation and decarbonylation. Antioxid. Redox Signal. 12, 393–404. 10.1089/ars.2009.280519686045
120. Xie Z. Cai T. (2003). Na+-K+–ATPase-mediated signal transduction: from protein interaction to cellular function. Mol. Interv. 3, 157–168. 10.1124/mi.3.3.15714993422
121. Xie Z. J. Wang Y. H. Askari A. Huang W. H. Klaunig J. E. (1990). Studies on the specificity of the effects of oxygen metabolites on cardiac sodium pump. J. Mol. Cell. Cardiol. 22, 911–920. 10.1016/0022-2828(90)90122-i2172559
122. Xie Z. Kometiani P. Liu J. Li J. Shapiro J. I. Askari A. (1999). Intracellular reactive oxygen species mediate the linkage of Na+/K+-ATPase to hypertrophy and its marker genes in cardiac myocytes. J. Biol. Chem. 274, 19323–19328. 10.1074/jbc.274.27.1932310383443
123. Yang L. E. P. Leong K. K. McDonough A. A. (2007). Reducing blood pressure in SHR with enalapril provokes redistribution of NHE3, NaPi2, and NCC and decreases NaPi2 and ACE abundance. Am. J. Physiol. Renal Physiol. 293, F1197–F1208. 10.1152/ajprenal.00040.200717652375
124. Yang L. E. Sandberg M. B. Can A. D. Pihakaski-Maunsbach K. McDonough A. A. (2008). Effects of dietary salt on renal Na+ transporter subcellular distribution, abundance, and phosphorylation status. Am. J. Physiol. Renal Physiol. 295, F1003–F1016. 10.1152/ajprenal.90235.200818653479
125. Yan Y. Shapiro A. P. Haller S. Katragadda V. Liu L. Tian J. et al. (2013). Involvement of reactive oxygen species in a feed-forward mechanism of Na/K-ATPase-mediated signaling transduction. J. Biol. Chem. 288, 34249–34258. 10.1074/jbc.m113.46102024121502
126. Yates N. A. McDougall J. G. (1995). Effect of volume expansion on the natriuretic response to ouabain infusion. Ren. Physiol. Biochem. 18, 311–320. 10.1159/0001739328711269
127. Yatime L. Buch-Pedersen M. J. Musgaard M. Morth J. P. Lund Winther A. M. Pedersen B. P. et al. (2009). P-type ATPases as drug targets: tools for medicine and science. Biochim. Biophys. Acta 1787, 207–220. 10.1016/j.bbabio.2008.12.01919388138
128. Yatime L. Laursen M. Morth J. P. Esmann M. Nissen P. Fedosova N. U. (2011). Structural insights into the high affinity binding of cardiotonic steroids to the Na+,K+-ATPase. J. Struct. Biol. 174, 296–306. 10.1016/j.jsb.2010.12.00421182963
129. Yudowski G. A. Efendiev R. Pedemonte C. H. Katz A. I. Berggren P. O. Bertorello A. M. (2000). Phosphoinositide-3 kinase binds to a proline-rich motif in the Na+, K+-ATPase alpha subunit and regulates its trafficking. Proc. Natl. Acad. Sci. U.S.A. 97, 6556–6561. 10.1073/pnas.10012829710823893
130. Zhang A. Y. Yi F. Zhang G. Gulbins E. Li P. L. (2006b). Lipid raft clustering and redox signaling platform formation in coronary arterial endothelial cells. Hypertension 47, 74–80. 10.1161/10.1161/01.HYP.0000196727.53300.6216344372
131. Zhang C. Imam S. Z. Ali S. F. Mayeux P. R. (2002). Peroxynitrite and the regulation of Na+,K+-ATPase activity by angiotensin II in the rat proximal tubule. Nitric Oxide 7, 30–35. 10.1016/S1089-8603(02)00003-412175817
132. Zhang S. Malmersjö S. Li J. Ando H. Aizman O. Uhlen P. et al. (2006a). Distinct role of the N-terminal tail of the Na,K-ATPase catalytic subunit as a signal transducer. J. Biol. Chem. 281, 21954–21962. 10.1074/jbc.M60157820016723354
133. Zhang Z. Devarajan P. Dorfman A. L. Morrow J. S. (1998). Structure of the ankyrin-binding domain of alpha-Na,K-ATPase. J. Biol. Chem. 273, 18681–18684. 10.1074/jbc.273.30.186819668035
134. Zuo L. Ushio-Fukai M. Ikeda S. Hilenski L. Patrushev N. Alexander R. W. (2005). Caveolin-1 is essential for activation of Rac1 and NAD(P)H oxidase after Angiotensin II Type 1 receptor stimulation in vascular smooth muscle cells: role in redox signaling and vascular hypertrophy. Arterioscler. Thromb. Vasc. Biol. 25, 1824–1830. 10.1161/01.ATV.0000175295.09607.1815976327